Breaking News on Supplements & Nutrition - North AmericaEU edition

Report abuse about a comment

Further comment on dubious study

As I stated a week ago in response to the recently released study on resveratrol, the fault here is with the study design and protocol itself, not the resveratrol used in the study. The dosage used in this study was ridiculously low, compared to all earlier studies. In the case of the successful Albert Einstein Medical School study and the more recent Florida Pharmacology School study the dosages were approximately 10 to 20 times this amount. This dosage is consistent with the supplements used in those trials, specifically biotivia transmax and bioforte, which are readily available without a prescription. Using a dosage of only 75mg was tantamount to giving a heart attack victim one aspirin.

In all previous studies on actual type 2 diabetic patients or those suffering impaired glucose tolerance, a sign of impending diabetes, resveratrol was extremely effective in improving glucose tolerance, enhancing metabolic function and blocking the onset of diabetes.

As a cell biologist who has been involved in several human clinical trials of transmax and bioforte resveratrol against diabetes, I can only imagine that this study was designed by a pharmaceutical company to fail intentionally. The pharmas are clearly aware of the potential of resveratrol to cut into their sales of Metformin, a multi-billion dollar earner for the drug companies, and are on a campaign to discredit the compound.

As a researcher I question why the clinicians in this study would select as subjects women who have no issues with glucose tolerance, who were non-obese, and who did not exhibit signs of diabetes. This is equivalent to testing a compound designed to treat cancer on a group of subjects none of whom has cancer. Again, we see a troubling signal of possible pharma involvement.

Posted by James Betz
01 November 2012 | 08h40

Please fill in the box below to tell us why you feel the post breaks our rules. When you are finished, click on "Send" so that it can be reviewed by a moderator.

Your name *
Your email *

We will not publish your email on the site

Reason *

Back to: Resveratrol study results don’t tell the whole story on benefits: Expert

Spotlight

Industry experts dispute dietary supplement critic Cohen's call for sweeping new regulations

Industry experts dispute dietary supplement critic Cohen's call for sweeping new regulations

A long time critic of the dietary supplement industry, Dr Pieter Cohen, MD, has called for a...

AHPA's new protein guidance addresses issue that has been percolating for years

AHPA's new protein guidance addresses issue that has been percolating for years

The American Herbal Products Association has set a new policy for how member companies ought to calculate...

Emerson Ecologics says new quality program will boost GMP compliance of brands it carries

Emerson Ecologics says new quality program will boost GMP compliance of brands it carries

Emerson Ecologics, which distributes a wide range of dietary supplements in the practictioner channel, has altered its...

ANVISA: Regulation must catch up to booming South American supplements market

ANVISA: Regulation must catch up to booming South American supplements market

Just ahead of the 2014 Vitafoods Conference in São Paulo, Brazil, a spokesperson for the Brazilian Health...

Omega-3s science is rock solid, but you don't win every game, expert says

Omega-3s science is rock solid, but you don't win every game, expert says

When scientists seek to counteract bad press for omega-3s it is a matter of taking two steps...

Integrated social media strategy drives supplement sampling startup's rapid growth

Integrated social media strategy drives supplement sampling startup's rapid growth

Having a social media strategy as a foundational piece of a business can yield huge dividends in...

InsideTracker CEO: ‘The one-size-fits-all intervention approach to nutrition makes no sense - Personalization is the future’

InsideTracker CEO: ‘The one-size-fits-all intervention approach to nutrition makes no sense - Personalization is the future’

It may have been said before, but the future of nutrition is through personalization, especially for athletic...

Chromadex CEO: ‘We think Niagen has a much bigger market, like omega-3’

Chromadex CEO: ‘We think Niagen has a much bigger market, like omega-3’

The potential of nicotinamide riboside, the next generation vitamin B3, goes beyond dietary supplements, into functional food...

Canadian group floats plan for algal omega-3s from dispersed bioreactors harvesting agricultural waste

Canadian group floats plan for algal omega-3s from dispersed bioreactors harvesting agricultural waste

Algae promoters usually talk big: Big ponds, banks of bioreactors, chemical process efficiencies and economies of scale. ...

Huge demand for omega-3 liquid products driving delivery innovations: Virun CEO

Huge demand for omega-3 liquid products driving delivery innovations: Virun CEO

Consumers like the delivery of omega-3 fatty acids in a liquid, and many innovative products are already...

Key Industry Events

 

Access all events listing

Our events, Events from partners...